Dr. Zhu is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1718 Braeswood Dr
Corpus Christi, TX 78412Phone+1 361-992-8500
Education & Training
- Creighton UniversityFellowship, Allergy and Immunology, 2011 - 2013
- Driscoll Children's Hospital/Texas A&M College of MedicineResidency, Pediatrics, 2008 - 2011
- Wenzhou Medical CollegeClass of 1987
Certifications & Licensure
- TX State Medical License 2012 - 2025
- IN State Medical License 2011 - 2013
- NE State Medical License Active through 2013
- American Board of Allergy and Immunology Allergy & Immunology
Publications & Presentations
PubMed
- 12 citationsEndogenous TNFalpha mediates cell survival and chemotherapy resistance by activating the PI3K/Akt pathway in acute lymphoblastic leukemia cells.Lubing Gu, Harry W. Findley, Ningxi Zhu, Muxiang Zhou
Leukemia. 2006-05-01 - 50 citationsAn alternatively spliced survivin variant is positively regulated by p53 and sensitizes leukemia cells to chemotherapy.Ningxi Zhu, Lubing Gu, Harry W. Findley, Fengzhi Li, Muxiang Zhou
Oncogene. 2004-09-30 - 79 citationsMDM2 antagonist nutlin-3 is a potent inducer of apoptosis in pediatric acute lymphoblastic leukemia cells with wild-type p53 and overexpression of MDM2Lubing Gu, Ningxi Zhu, Harry W. Findley, Muxiang Zhou
Leukemia. 2008-02-14
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: